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Endoscopic resection (ER) of undifferentiated-type early gastric cancer (UD-EGC) has a lower curative resection (CR) rate than 
differentiated-type EGC. However, if UD-EGC is curatively resected using ER, long-term outcomes can be favorable. Thus, the strategy 
for CR by ER is important in UD-EGC. To achieve CR in UD-EGC, biological behaviors including tumor growth patterns must be 
considered. This review aims to describe what is important for curative ER of UD-EGC. clin endosc  2019;52:9-14
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INTRODUCTION
Although endoscopic resection (ER) is a standard treat-
ment for early gastric cancer (EGC) without lymph node 
metastasis (LNM), ER is performed more carefully in cases of 
undifferentiated-type EGC (UD-EGC) than in cases of differ-
entiated-type EGC (D-EGC). This may be because the undif-
ferentiated-type histology has been known to show aggressive 
biologic behavior in gastric cancer. According to a recent 
systematic review, the risk of LNM in UD-EGC cases that 
met the expanded criteria of ER was significantly increased 
compared with the risk in cases that met the absolute criteria.1 
Nonetheless, many studies have reported the feasibility of ER 
in UD-EGC based on long-term follow-up outcome data.2-6 
When curatively resected using ER, the long-term outcomes 
are favorable in UD-EGC.2-6 However, the curative resection 
(CR) rate after ER is reportedly lower in cases of UD-EGC 
than in cases of D-EGC.2-4,6 This review aims to describe what 
is important for curative ER in UD-EGC. 
HISTOlOGIC DIaGNOSIS 
The histologic diagnosis is very important in the choice of 
treatment modality for EGC. In particular, discriminating 
between differentiated- and undifferentiated-type histology in 
EGC is important because the indications for ER differ. The 
situation becomes more complicated when the differentiat-
ed-type histology before ER changes to undifferentiated-type 
histology after ER. To achieve CR after ER in UD-EGC, it is 
important to identify undifferentiated-type histology before 
ER. Thus, several studies investigated the factors associated 
with UD-EGC exhibiting differentiated-type histology on 
biopsy. Moderately differentiated histology on biopsy, size >2 
cm, and body location were associated with UD-EGC exhibit-
ing differentiated histology on biopsy.7-9 Tumor gross appear-
ance can also be helpful for predicting the histologic findings. 
As the endoscopic elevated gross type is strongly associated 
with D-EGC,10,11 a recent study suggested that the presence of 
elevated-type EGC may exclude UD-EGC without need for a 
biopsy.10   
Most of all, the accuracy of histologic diagnosis is import-
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ant. For target biopsy or histologic predictions, image-en-
hanced endoscopy or laser endomicroscopy can be helpful. 
A targeted biopsy based on confocal laser endomicroscopy 
found a higher proportion of cancer cells in biopsy samples 
with undifferentiated-type histology, including poorly differ-
entiated adenocarcinoma (PD) and signet ring cell carcinoma 
(SRC), than that based on white-light endoscopy.12 On white-
light endoscopy, the actual biopsy site may be important 
according to a previous histopathological mapping study.7 
UD-EGC cases that exhibited differentiated-type histology on 
biopsy frequently had a zone of transition from differentiated- 
to undifferentiated-type histology in ER specimens.7 The zone 
of transition occurred in one or two peripheral regions of the 
lesion.7 Therefore, a biopsy of several peripheral sites can be 
helpful in making an accurate diagnosis of UD-EGC before 
ER.7  
DIFFERENCES wITHIN UD-EGC: PD vS. 
SRC 
ER is performed according to the Japanese histological 
classification of differentiated- and undifferentiated-type his-
tology. According to a previous World Health Organization 
pathological classification, PD and SRC are undifferentiat-
ed-type histology types. The present indication for ER is the 
same as for undifferentiated-type histology, with no difference 
between PD and SRC. To date, there has been no evidence 
that different criteria should be applied in cases of PD vs. SRC. 
The long-term outcomes of ER reportedly do not differ be-
tween PD and SRC cases.3,6 
Nonetheless, biological behaviors differ between PD and 
SRC. UD-EGC cases generally show higher frequencies of 
LNM than D-EGC cases; thus, the present criteria for ER are 
stricter in UD-EGC cases than in D-EGC cases. However, in 
EGC, SRC shows a better prognosis with less LNM than non-
SRC.13-16 Growth patterns of cancer cells differ between PD 
and SRC, as known from their predominant gross appearance. 
The predominant gross appearance of EGC was the depressed 
type in PD, with a more infiltrative growth pattern of tumor 
cells, versus the flat type in SRC, with a spreading growth 
pattern of tumor cells.3,11,17 That is, cancer cells in PD have a 
vertical growth pattern, whereas those in SRC have a horizon-
tal growth pattern.3,6,11,17 The different growth patterns of PD 
and SRC are reflected in the different results after ER. After 
ER, the main cause of non-CR differed between PD and SRC, 
based on a positive vertical margin in PD vs. a positive lateral 
margin in SRC.3,6,17 Therefore, different strategies for PD and 
SRC are necessary to achieve CR after ER. For PD, accurate 
prediction of invasion depth is important, in contrast with 
that of tumor lateral extent for SRC.3,17
Further investigations are necessary to determine the opti-
mal pre-ER evaluation. The most important step is evaluating 
whether LNM is present on computed tomography and/or 
endoscopic ultrasonography (EUS). Furthermore, the risk of 
LNM should be evaluated by examining invasion depth and 
tumor extent. However, the role of image-enhanced endos-
copy and EUS in the accurate prediction of invasion depth 
or tumor extent should be investigated. There is currently no 
solid evidence for the routine application of EUS or image-en-
hanced endoscopy in pre-ER evaluation. 
Considering vertical margin positive status after ER in PD, 
EUS with strict criteria may be helpful in accurately predict-
ing invasion depth despite the possibility of underestimation 
using EUS in PD.18,19 
To predict tumor extent in UD-EGC, chromoendosco-
py and narrow-band imaging with magnifying endoscopy 
(NBI-ME) were not helpful, in contrast with their value in 
D-EGC.20,21 Thus, a Japanese algorithm recommended biop-
sies from the surrounding mucosa to delineate unclear tumor 
margins in UD-EGC,22 because SRC often shows a subepithe-
lial spread pattern without superficial mucosal change. How-
ever, studies recently reported that NBI-ME can be helpful for 
accurately predicting tumor extent in UD-EGC.23-25 Based on 
the change in mucosal layer according to cancer cell infiltra-
tion, these studies categorized the findings of NBI-ME into 
three patterns: an extended intervening component pattern 
(tumor confined to the proliferative zone); a wavy microvessel 
pattern (tumor extending from the superficial layer to the 
proliferative zone); and a corkscrew pattern (tumor involving 
the entire mucosa).23-25 The corkscrew pattern is a well-known 
finding of NBI-ME in UD-EGC. However, this pattern can be 
found when tumor cells occupy the entire mucosa. The other 
two patterns have probably been missed by NBI-ME, which 
is why the role of NBI-ME has been limited in UD-EGC un-
til now. To accurately predict tumor extent, NBI-ME can be 
helpful based on these three types, according to the sites occu-
pied by tumor cells in SRC. 
Tumor growth pattern may be predicted based on the sur-
rounding mucosa in SRC.26 According to a previous report, 
the mucosa surrounding SRC may be an important mechan-
ical barrier to tumor cell spread. Thus, SRC surrounded by 
atrophy or intestinal metaplasia may spread in a subepithelial 
manner.26 When SRC is surrounded by atrophy or intestinal 
metaplasia, tumor extent should be carefully delineated (Fig. 
1). 
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SITUaTION aFTER ER: mIxED 
HISTOlOGy aND SaFETy maRGIN  
The histologic situation prior to ER is simplified when cases 
are classified as having differentiated- or undifferentiated-type 
histology. However, after ER, the histologic situation can 
become complex (e.g., mixed histology due to histologic het-
erogeneity within the tumor). The mixed type in the Lauren 
classification includes components of the intestinal type (50%) 
and the diffuse type (50%). However, most tumors have a pri-
mary histology with a minor histologic component (<50%). 
The present ER criteria did not include mixed histology or 
minor histologic components.
Mixed histology, including undifferentiated-type histology 
as the primary or minor component, shows aggressive bio-
logic behavior, compared with that in the non-mixed type.27-29 
EGC with an SRC minor component showed a higher degree 
of LNM than cases without an SRC minor component.13 SRC 
is known to have less frequent LNM than PD; however, mixed 
SRC as a minor component can show more aggressive be-
havior than other histologies, including PD.13 Among D-EGC 
cases, lesions with a minor PD component showed higher 
frequencies of LNM than those without a PD component.29,30 
In previous studies, a mixed histology in EGC was associated 
with a larger tumor size, submucosal invasion, more lympho-
vascular invasion, and higher LNM rates than in cases with a 
non-mixed histology.28,31-37 However, treatment outcomes after 
ER are inconsistent; some studies reported a higher non-CR 
rate and local recurrence, whereas some reported favorable 
long-term outcomes.33,35 
Thus, are new ER criteria for mixed histology in EGC 
necessary? One study investigated LNM rates according to 
ER criteria in mixed histology cases. The study included SRC 
cases with mixed histology, mixed-type Lauren classification, 
and differentiated- or undifferentiated-predominant mixed-
type as mixed histology cases.32 Lesions categorized as mixed 
histology in 3,419 EGC cases (49.7% differentiated-type; 50.3% 
undifferentiated-type) were investigated for LNM rates using 
the present ER criteria. The results showed that LNM was not 
found in lesions that met the present ER criteria.32 
Another important factor in achieving CR is the patholog-
ical safety margin after ER. There is currently no definition of 
the ideal pathological safety margin after ER in EGC. Thus, 
complete resection after ER is defined as no cancer cell expo-
sure to any resected margin with a line between normal tissue 
and the portion denatured by burning.17 To investigate the 
optimal pathological safety margin after ER, it is important to 
analyze risk factors for residual tumors in cases of completely 
resected EGC after ER. According to the study, a safety mar-
gin of <3 mm (odds ratio [OR], 13.8), PD (OR, 16.3), and SRC 
(OR, 9.8) were significantly associated with residual tumors 
after ER.38 That is, UD-EGC including both PD and SRC is 
an independent risk factor for the presence of residual tumor 
cells after negative resected margins are found in ER speci-
mens. Furthermore, the pathological safety margin after ER 
may be >3 mm.38 This safety margin can be important, espe-
A B
Fig. 1. Signet ring cell carcinoma (SRC) case with positive lateral margin after endoscopic resection. (A) Endoscopic image of early gastric cancer, showing a de-
pressed lesion located in the posterior wall of the angle. The surrounding mucosa was combined with atrophic gastritis. After endoscopic resection, the lateral margin 
was positive (arrow). (B) Pathological findings after endoscopic resection (hematoxylin and eosin, ×40). SRC cells showed subepithelial spread. Immunohistochemical 
staining for CK (AE1/AE3), ×100.
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cially in cases of UD-EGC.
STRaTEGy FOR aCHIEvING CR USING 
ER IN UD-EGC 
Fig. 2 shows a suggested algorithm for achieving curative 
ER in cases of UD-EGC, based on the findings of previous 
studies.39 
An accurate histologic diagnosis prior to ER is more im-
portant in UD-EGC than in D-EGC for CR after ER. Differ-
ent tumor growth patterns should be considered for PD and 
SRC. For PD, the prediction of invasion depth can be import-
ant, whereas for SRC, tumor extent is important. To predict 
tumor extent accurately in SRC, tumor cell involvement of 
the mucosal layer can be important. After ER, when a mixed 
histology is observed, the current ER criteria can be applied 
based on major histologic type. After CR by ER, if the patho-
logical safety margin is <3 mm, short-term follow-up with 
biopsy at the resected base may be necessary to evaluate the 
risk of residual tumor development. 
CONClUSIONS
ER of UD-EGC has a lower CR rate than D-EGC. However, 
Fig. 2. Suggested algorithm for endoscopic resection (ER) of undifferentiated-type early gastric cancer (UD-EGC) based on previous studies (Modified from Kim39). 
PD, poorly differentiated adenocarcinoma; SRC, signet ring cell carcinoma; EUS, endoscopic ultrasonography; IM, intestinal metaplasia; NBI-ME, narrow-band imag-
ing with magnifying endoscopy.
UD-EGC
Within current ER criteria
A pathological safety margin greater than 3 mm
Short-term follow-up with
biopsy at resected base Routine follow-up
Endoscopic appearance
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- Surrounded with atrophy and/or IM
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if UD-EGC is curatively resected using ER based on the cur-
rent criteria, long-term outcomes can be favorable. Thus, the 
strategy for CR by ER is important in UD-EGC. To achieve 
CR in UD-EGC, different biological behaviors, including 
tumor growth patterns between histologic types must be 
considered. Considering the growth patterns of cancer cells, 
prediction of invasion depth and lateral extent can be diffi-
cult in PD and SRC, respectively. Thus, advanced endoscopic 
tools including image-enhanced endoscopy or confocal laser 
endomicroscopy should be supplemented and developed to 
overcome these difficulties. After ER, the risk of residual tu-
mor development should be carefully assessed in UD-EGC. 
A pathological safety margin >3 mm may reduce the risk of 
residual tumor cells after ER. 
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